Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
May 26, 2022
Tryp Therapeutics Strengthens Board of Directors with Appointment of Chris Ntoumenopoulos as Independent Director
May 25, 2022
High Tide Subsidiary Blessed CBD Launches Subscribe-and-Save Discount Program in the U.K. Market
May 25, 2022